In a revelation that is sending shockwaves through political and medical circles, BBC News has reported that former President Donald Trump was seen using Mometasone cream during his last public appearance. While on the surface this may seem like a minor detail, the BBC confirms that Trump has been diagnosed with chronic hypoparathyroidism—a rare but serious condition that can cause skin ulcers, tissue damage, and even putrefaction if left untreated. The news has fueled intense speculation about Trump’s health, his fitness to maintain a grueling public schedule, and his long-term prospects in the political arena.

A Rare Condition With Serious Risks

Hypoparathyroidism occurs when the parathyroid glands fail to produce sufficient levels of parathyroid hormone (PTH). This hormone regulates calcium and phosphorus in the body, both of which are essential for muscle, nerve, and bone function. In Trump’s case, the chronic form of the disease raises more serious concerns. Doctors warn that individuals suffering from this condition can develop persistent muscle cramps, neurological complications, and brittle bones.

More alarmingly, one of the lesser-known but devastating effects is on the skin. Patients are prone to developing non-healing ulcers, chronic infections, and necrosis, particularly when calcium levels are not managed properly. The use of Mometasone cream, a steroid-based topical medication, suggests Trump may already be struggling with skin lesions or irritation related to his condition.

What Mometasone Reveals

Mometasone furoate is commonly prescribed to reduce inflammation, itching, and allergic reactions on the skin. However, in the context of chronic hypoparathyroidism, its use is telling. Experts note that applying steroid cream could be part of an attempt to manage painful sores or prevent them from worsening.

“The fact that he’s using Mometasone in public indicates the condition is not being fully controlled internally,” explained one dermatologist interviewed after the BBC’s revelation. “It is very possible he is developing visible ulcers that require immediate management. This is not just cosmetic—it points to deeper systemic issues.”

A Political Firestorm

Unsurprisingly, the report has set off a firestorm in the political world. Trump’s rivals argue that this condition, combined with his age, raises legitimate questions about whether he is physically capable of sustaining another presidential campaign or holding office. Critics on social media were quick to circulate photos of Trump at recent rallies, zooming in on what they claimed were discolored patches on his hands and face.

Meanwhile, Trump’s supporters dismissed the report as another media hit job designed to undermine his political momentum. “The BBC is exaggerating—he’s as strong as ever,” wrote one prominent conservative commentator. “They’ll do anything to scare voters.”

Still, even some of Trump’s allies privately admit they are worried. Behind the scenes, discussions have reportedly taken place about limiting his exposure to harsh campaign schedules, late-night events, and long flights, all of which could exacerbate his fragile health.

The Medical Clock is Ticking

What makes this situation particularly dire is the progressive nature of chronic hypoparathyroidism. Without strict management—often involving daily supplements of calcium and vitamin D analogs—patients face ongoing deterioration. In severe cases, ulcers can deepen into wounds that refuse to heal, opening the door to life-threatening infections.

Doctors warn that if Trump does not receive specialized treatment and monitoring, his condition could quickly spiral into something far more dangerous. “Putrefaction” is not a word used lightly in medicine, yet experts stress it is a genuine risk when circulation and skin integrity are compromised by the disease.

Public Transparency Demanded

The revelation has also sparked a new debate about transparency in political health disclosures. In the past, presidential candidates have been reluctant to release full medical records, often dismissing concerns as partisan attacks. But in Trump’s case, the visible nature of the condition—and the BBC’s reporting—makes it harder to ignore.

“What voters deserve is honesty,” one political analyst argued. “If a candidate is dealing with a chronic illness that could affect their ability to serve, the public has a right to know. The secrecy only fuels distrust.”

What Comes Next

As of now, Trump has not publicly addressed the BBC’s claims. His inner circle has remained tight-lipped, offering no comment when pressed by reporters. Yet silence may no longer be a viable strategy. The sight of a former president visibly treating a condition that could lead to ulceration and tissue decay will not fade from the public consciousness anytime soon.

Ultimately, Trump faces two battles: one against a rare and debilitating disease, and another against the relentless spotlight of politics. Whether he can withstand both remains to be seen, but one thing is clear—the questions about his health are not going away.